By 2015, most pharmaceutical companies had formed “patient engagement” departments and regularly enlisted the help of Patient Advocates to serve on Advisory Panels, summarizing the patient experience on behalf of the entire population. In addition to recognizing a need to include a more realistic patient sample, efforts to include patient collaboration in early drug development were also underway.

Clinical Trials:  For the first time in the mid 2010’s, industry begins enlisting the help of patients, via Advisory Panels, to help develop new strategies for all phases of the Research & Development continuum, with a focus on clinical trials.

 

CoPI: Mentor Assisted Research (MAR), co-production of stakeholder groups, advisory panel

Tools: Reports – patient engagement

Context: Qualitative research, Research & Development, clinical trials